Efficacy, Safety Profiles and Outcomes of Dual Anti Her2 Blockade in Combination with Neoadjuvant Chemotherapy in Locally Advanced (Stage II-III) Her2 Expressing Breast Cancer Patients, Middle East Experience.

Autor: Alsayed, Adher1, Badran, Ahmed1,2, Elashwah, Ahmed1,3, Gad, Ahmed1,2, Shahin, Amgad1,4, Omar, Ayman1,5, KHAN, Khurshid1, Shentenawi, Ayman1,3, AL-Tweigeri, Taher1, Ajarim, Dahish1, Haque, E.6, Mushtaq, A.6, Suleman, Kauser1
Zdroj: Pan Arab Journal of Oncology. 2018 special issue, p57-63. 7p.
Databáze: Academic Search Ultimate